What are the cost considerations for preimplantation genetic testing for aneuploidy?
The study by Somigliana et al. (1) addresses an important and timely clinical question: Is preimplantation genetic testing for aneuploidies (PGT-A) a cost-effective adjunct in IVF? We appreciate the continued study into this aspect of IVF patient care and counseling, which is rapidly expanding in utilization and yet remains controversial. The authors conclude that PGT-A can be cost-effective in specific settings and populations, namely with increasing female age and the number of available blastocysts (1).
Source: fertstert.org
What are the cost considerations for preimplantation genetic testing for aneuploidy?
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment